Ceapro Inc
XTSX:CZO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Ceapro Inc
Other Receivables
Ceapro Inc
Other Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Ceapro Inc
XTSX:CZO
|
Other Receivables
CA$216.8k
|
CAGR 3-Years
28%
|
CAGR 5-Years
36%
|
CAGR 10-Years
-3%
|
|
|
Burcon NutraScience Corp
TSX:BU
|
Other Receivables
CA$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
EcoSynthetix Inc
TSX:ECO
|
Other Receivables
$306.6k
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-8%
|
|
|
5N Plus Inc
TSX:VNP
|
Other Receivables
$1.9m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-14%
|
|
|
Nano One Materials Corp
TSX:NANO
|
Other Receivables
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Neo Performance Materials Inc
TSX:NEO
|
Other Receivables
$2.2m
|
CAGR 3-Years
76%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
Ceapro Inc
Glance View
Ceapro, Inc. engages in the development and marketing of natural products for personal care, cosmetic, human, and animal health industries. The company is headquartered in Edmonton, Alberta. The firm's primary business activities relate to the development and marketing of various health and wellness products and technology relating to plant extracts. The firm operates through two segments: the active ingredient product technology industry and the cosmeceutical industry. The firm is engaged in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. The company supports the use of its extracts in cosmeceutical, nutraceutical and therapeutic products for humans and animals. Its pipeline Oat Beta Glucan and Avenanthramides. The Company’s wholly owned subsidiaries include Ceapro Technology Inc., Ceapro Active Ingredients Inc., Ceapro BioEnergy Inc., Ceapro (P.E.I) Inc., Ceapro USA Inc., and JuventeDC Inc.
See Also
What is Ceapro Inc's Other Receivables?
Other Receivables
216.8k
CAD
Based on the financial report for Dec 31, 2023, Ceapro Inc's Other Receivables amounts to 216.8k CAD.
What is Ceapro Inc's Other Receivables growth rate?
Other Receivables CAGR 10Y
-3%
Over the last year, the Other Receivables growth was 235%. The average annual Other Receivables growth rates for Ceapro Inc have been 28% over the past three years , 36% over the past five years , and -3% over the past ten years .
